LMAT - LeMaitre Vascular, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
34.56
-0.55 (-1.57%)
At close: 4:00PM EST

34.87 +0.31 (0.89%)
After hours: 4:23PM EST

Stock chart is not supported by your current browser
Previous Close35.11
Open34.92
Bid28.10 x 100
Ask39.00 x 100
Day's Range34.38 - 35.11
52 Week Range19.82 - 39.88
Volume201,445
Avg. Volume208,946
Market Cap665.79M
Beta0.56
PE Ratio (TTM)49.37
EPS (TTM)0.70
Earnings DateOct 24, 2017 - Oct 30, 2017
Forward Dividend & Yield0.22 (0.64%)
Ex-Dividend Date2017-11-21
1y Target Est33.00
Trade prices are not sourced from all markets
  • Should You Buy LeMaitre Vascular Inc (LMAT) Now?
    Simply Wall St.16 hours ago

    Should You Buy LeMaitre Vascular Inc (LMAT) Now?

    LeMaitre Vascular Inc (NASDAQ:LMAT), a healthcare equipment and supplies company based in United States, saw a double-digit share price rise of over 10% in the past couple of months onRead More...

  • 3 Unknown, but Amazing, Dividend Stocks
    Motley Fool10 days ago

    3 Unknown, but Amazing, Dividend Stocks

    Looking for a few little-known income gems? Check out these three businesses.

  • GlobeNewswire16 days ago

    LeMaitre Vascular to Present at Upcoming November and December Investor Conferences

    BURLINGTON, Mass., Nov. 01, 2017-- LeMaitre Vascular, Inc. announced today that it will be participating in six investor conferences in November and December.. JJ Pellegrino, Chief Financial Officer, is ...

  • Thomson Reuters StreetEvents17 days ago

    Edited Transcript of LMAT earnings conference call or presentation 26-Oct-17 9:00pm GMT

    Q3 2017 LeMaitre Vascular Inc Earnings Call

  • Capital Cube17 days ago

    LeMaitre Vascular, Inc. – Value Analysis (NASDAQ:LMAT) : October 31, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives LeMaitre Vascular, Inc. a score of 81. Our analysis is based on comparing LeMaitre Vascular, Inc. with the following peers – AngioDynamics, Inc., Endologix, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Cardiovascular Systems, Inc., C. R. Bard, Inc., Baxter International Inc. and Teleflex Incorporated (ANGO-US, ELGX-US, BSX-US, ... Read more (Read more...)

  • Capital Cube18 days ago

    ETFs with exposure to LeMaitre Vascular, Inc. : October 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to LeMaitre Vascular, Inc. Here are 5 ETFs with the largest exposure to LMAT-US. Comparing the performance and risk of LeMaitre Vascular, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : October 30, 2017
    Capital Cube19 days ago

    LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : October 30, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for LeMaitre Vascular, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Why LeMaitre Vascular Inc. Is Plunging Today
    Motley Fool21 days ago

    Why LeMaitre Vascular Inc. Is Plunging Today

    Traders flee after the company reports lower-than-expected quarterly revenue and shares disappointing guidance. Does this drop represent a buying opportunity?

  • Associated Press22 days ago

    LeMaitre beats 3Q profit forecasts

    On a per-share basis, the Burlington, Massachusetts-based company said it had profit of 25 cents. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

  • GlobeNewswire22 days ago

    LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%)

    BURLINGTON, Mass., Oct. 26, 2017-- LeMaitre Vascular, Inc., a provider of vascular devices, implants and services, today reported Q3 2017 results, provided guidance, and announced a $0.055/ share dividend. ...

  • ACCESSWIRE22 days ago

    LeMaitre Vascular, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / October 26, 2017 / LeMaitre Vascular, Inc. (NASDAQ: LMAT ) will be discussing their earnings results in their Q3 Earnings Call to be held on October 26, 2017 at 5:00 PM Eastern ...

  • GlobeNewswirelast month

    LeMaitre Vascular Will Announce Third Quarter 2017 Earnings Results on October 26, 2017

    BURLINGTON, Mass., Oct. 16, 2017-- LeMaitre Vascular, Inc. announced today that it will release its third quarter 2017 financial results on Thursday, October 26, 2017, after the market close. The company ...

  • Capital Cube2 months ago

    ETFs with exposure to LeMaitre Vascular, Inc. : September 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to LeMaitre Vascular, Inc. Here are 5 ETFs with the largest exposure to LMAT-US. Comparing the performance and risk of LeMaitre Vascular, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Stocks With Rising Relative Strength: Penumbra
    Investor's Business Daily2 months ago

    Stocks With Rising Relative Strength: Penumbra

    A Relative Strength Rating upgrade for Penumbra shows improving technical performance. Will it continue?

  • 5 MedTech Stocks to Pick for Stellar Returns
    Zacks2 months ago

    5 MedTech Stocks to Pick for Stellar Returns

    While the MedTech industry has been grappling with multiple issues, these stocks with high growth potential can be great bets.

  • 3 Dividend Healthcare Stocks
    Motley Fool2 months ago

    3 Dividend Healthcare Stocks

    Looking for income from the healthcare sector? Here's why you should check out Gilead Sciences, Allergan, and LeMaitre Vascular.

  • Capital Cube2 months ago

    ETFs with exposure to LeMaitre Vascular, Inc. : September 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to LeMaitre Vascular, Inc. Here are 5 ETFs with the largest exposure to LMAT-US. Comparing the performance and risk of LeMaitre Vascular, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017
    Capital Cube2 months ago

    LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017

    Categories: Yahoo FinanceGet free summary analysis LeMaitre Vascular, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of LeMaitre Vascular, Inc. – Endologix, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Cardiovascular Systems, Inc., C. R. Bard, Inc., Baxter International Inc. and Teleflex Incorporated (ELGX-US, BSX-US, EW-US, ... Read more (Read more...)

  • 5 Top-Ranked MedTech Growth Stocks for Solid Returns
    Zacks2 months ago

    5 Top-Ranked MedTech Growth Stocks for Solid Returns

    Despite the ongoing turmoil in the MedTech industry, these stocks with high growth potential can be great bets for investors.

  • Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead
    Zacks2 months ago

    Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead

    The share price performance of Abbott Laboratories (ABT) has been disappointing over the last three years. Of the prime issues plaguing Abbott, foreign exchange is a major one.

  • GlobeNewswire2 months ago

    LeMaitre Vascular to Present at Upcoming Investor Conferences

    BURLINGTON, Mass., Sept. 05, 2017-- LeMaitre Vascular, Inc. announced today that it will be participating in three investor conferences.. JJ Pellegrino, Chief Financial Officer, is scheduled to present ...

  • Why LeMaitre Vascular (LMAT) Could Be Positioned for a Surge
    Zacks3 months ago

    Why LeMaitre Vascular (LMAT) Could Be Positioned for a Surge

    LeMaitre Vascular (LMAT) is seeing solid earnings estimate revisions, and the stock is showing decent short-term momentum as well.

  • Capital Cube3 months ago

    LeMaitre Vascular, Inc. – Value Analysis (NASDAQ:LMAT) : August 14, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives LeMaitre Vascular, Inc. a score of 81. Our analysis is based on comparing LeMaitre Vascular, Inc. with the following peers – AngioDynamics, Inc., Endologix, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Cardiovascular Systems, Inc., C. R. Bard, Inc., Baxter International Inc. and Teleflex Incorporated (ANGO-US, ELGX-US, BSX-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of LMAT earnings conference call or presentation 27-Jul-17 9:00pm GMT

    Q2 2017 LeMaitre Vascular Inc Earnings Call

  • Forbes3 months ago

    Heart-Felt Buys: 6 Cardiac Opportunities

    Six biotech companies developing treatment and monitoring of heart disease are investing ideas that five advisors highlight.